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Abstract
Objective: To assess variations in decisions to revascularise patients with coronary heart disease
between general cardiologists, interventional cardiologists and cardiac surgeons
Design: Six cases of coronary heart disease were presented at an open meeting in a standard
format including clinical details which might influence the decision to revascularise. Clinicians (n =
53) were then asked to vote using an anonymous electronic system for one of 5 treatment options:
medical, surgical (CABG), percutaneous coronary intervention (PCI) or initially medical proceeding
to revascularisation if symptoms dictated. Each case was then discussed in an open forum following
which clinicians were asked to revote. Differences in treatment preference were compared by chi
squared test and agreement between groups and between voting rounds compared using Kappa.
Results: Surgeons were more likely to choose surgery as a form of treatment (p = 0.034) while
interventional cardiologists were more likely to choose PCI (p = 0.056). There were no significant
differences between non-interventional and interventional cardiologists (p = 0.13) in their choice
of treatment. There was poor agreement between all clinicians in the first round of voting (Kappa
0.26) but this improved to a moderate level of agreement after open discussion for the second vote
(Kappa 0.44). The level of agreement among surgeons (0.15) was less than that for cardiologists
(0.34) in Round 1, but was similar in Round 2 (0.45 and 0.45 respectively)
Conclusion: In this case series, there was poor agreement between cardiac clinical specialists in
the choice of treatment offered to patients. Open discussion appeared to improve agreement.
These results would support the need for decisions to revascularise to be made by a
multidisciplinary panel.
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Background
Coronary revascularisation rates vary widely and are not
explained by geographical variations in the incidence of
coronary artery disease (CAD) [1-3]. Previous studies
from North America have suggested that variations tend
to reflect inappropriately high thresholds in low fre-
quency areas, rather than overuse elsewhere [4]. A recent
study suggested that under use of revascularisation results
in preventable morbidity and mortality [5].
Following detection of CAD at coronary angiography, two
decisions must be made: whether to attempt revasculari-
sation and whether to do this via coronary artery bypass
grafting (CABG) or percutaneous coronary intervention
(PCI). Both decisions are commonly made by the cardiol-
ogist. Some have argued that this represents a conflict of
interest for an interventional cardiologist [6,7] who acts as
both "poacher" and "gamekeeper". This issue has become
increasingly important as the use of PCI has grown and
CABG rates have fallen [8].
We used standardised case scenarios to examine variations
in decisions related to coronary revascularisation among
cardiologists and cardiac surgeons.
Methods
Six patients with coronary artery disease were presented in
a standard format to 53 cardiac specialists at an open
meeting. Cases were selected for presentation by a panel
of cardiologists on the basis that they represented typical
cases of coronary artery disease. Before any discussion or
voting, cases were presented to the audience in a standard
format including the clinical presentation, details of co-
morbidity, medication and results of stress testing. Digital
recordings of left ventriculography and coronary angiog-
raphy were also presented (table 1). An electronic keypad
voting system was used to identify the type of clinician
present (non-interventional cardiologist, interventional
cardiologist, cardiac surgeon, table 2) After each case pres-
entation the individual clinician was asked to vote using
the keypad for one of five treatment categories:
1. coronary artery by-pass grafting, 2. medical treatment
initially with a view to CABG if symptoms dictated, 3. cor-
onary angioplasty, 4. medical treatment initially with a
view to PCI if symptoms dictated, 5. medical therapy.
Cases were presented in succession with voting after each
presentation until all 6 had been presented, initially with
no discussion. Each case was then discussed in an open
forum led by a panel of experts with the audience asked to
participate in the discussion. The cases were then pre-
sented for a second time and everyone was asked to revote
on their treatment category (1–5) for each case. The
responses by the participants have also been compared to
treatment recommendations based on the New Zealand
score [9] (score greater than 35 points merits revasculari-
Table 1: Clinical details of the six cases as presented
Patient Age Presentation Stress 
Test
LV 
function
Severity CAD Co-morbitity Drug 
therapy
NZ score ACRE 
score
A 54 Unstable Positive Good 3VD Mild asthma Oral ×3 69 CABG
B 65 Stable Positive Good 3VD incl LMS Obese Oral ×2 60 CABG
C 74 Unstable Not done Good 3VD excl prox LAD Rheumatoid Oralx3 60 CABG or PCI
D 61 Stable Positive Good 3VD Osteoarthritis Oral ×2 65 CABG
E 64 Stable Positive Good 3VD Obese, HBP Oral ×2 30 CABG
F 67 Stable Positive Moderate 2VD excl prox LAD None Oral ×1 43 Uncertain
Key : Stress test – exercise test, positive is defined as >2 mm ST depression, CAD – coronary artery disease, VD – vessel disease, LMS – left main 
stem, LAD – left anterior descending artery, exc – excluding, prox – proximal, NZ score – New Zealand score (>35 merits revascularisation) [8], 
HBP – hypertension, Drug therapy – oral – 1,2 or 3 oral anti-anginal drugs, ACRE score (see reference 9), CABG – coronary artery by-pass 
grafting, PCI – percutaneous coronary intervention.
Table 2: Treatment preference by specialty in round 1 (numbers of individuals/cases)
Cardiac surgeons Interventional 
cardiologists
Non-interventional 
cardiologists
Total
CABG 25 (53%) 31 (40%) 56 (42%) 112 (43%)
PCI 5 (11%) 23 (30%) 28 (21%) 56 (22%)
Medical 17 (36%) 23 (30%) 50 (37%) 90 (35%)
Missing 1 7 52 60
Total 48 84 186 318Journal of Cardiothoracic Surgery 2006, 1:2 http://www.cardiothoracicsurgery.org/content/1/1/2
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sation) and the ACRE study which used a multidiscipli-
nary panel to rate the criteria for selecting patients for
coronary revascularisation [10].
Statistical analysis
The responses for each individual were summed over each
response category, so that each individual (who answered
all six Round 1 questions) contributes 6 observations to
the analysis. Due to the small number of participants in
certain response categories, some analysis used grouped
responses. The "medical" treatments were grouped
together and compared with angioplasty and surgery sep-
arately, and angioplasty and surgery together. The occupa-
tions "cardiologist" and "other cardiologists/physicians
with cardiology interest" were grouped into "non-inter-
ventional cardiologists". Results were compared by the χ2
test. Round 1 responses were compared to Round 2 for
each of the six cases. The weighted Kappa statistic was
employed for analysis as it has been specifically designed
to measure the level of agreement between two raters or
evaluators. However, it was also used to measure the level
of agreement between Round 1 and Round 2. A Kappa sta-
tistic of 0.00–0.40 suggests "poor" agreement, 0.41–0.60
"moderate" agreement, 0.61–0.75 "substantial" agree-
ment, 0.76–0.99 "excellent" agreement and 1.00 repre-
sents "perfect" agreement [11].
Results
Surgeons were more likely to choose surgery as a form of
treatment (table 2, P = 0.034,) while interventional cardi-
ologists were more likely to choose PCI (P = 0.056). There
were no differences in the form of treatment selected by
non-interventional cardiologists compared with interven-
tional cardiologists (P = 0.13).
There was poor agreement between all clinicians in the
first round of voting (table 3, Kappa 0.26) but this
improved to a moderate level of agreement after open dis-
cussion for the second vote (Kappa 0.44). The level of
agreement among surgeons (0.15) was less than that for
cardiologists (0.34) in Round 1, but was similar in Round
2 (0.45 and 0.45 respectively).
Two patients (C and E) produced significant differences in
treatment preference between round 1 and round 2 of vot-
ing suggesting that the discussion between rounds had
produced an overall change in clinical opinion (table 3).
Both of these patients had significant co-morbidity which
may have influenced the choice of treatment with one
swinging from predominantly surgery to angioplasty and
the other from an equal number of angioplasty and med-
ical to predominantly medical therapy. Overall, compar-
ing the pattern of votes between rounds 1 and 2, there was
a small non-significant reduction in the number of votes
for medical therapy alone with an increased number of
votes for medical therapy followed by either PCI or CABG
if symptoms dictated and no significant increase in the
overall use of revascularisation (table 4).
There was no relationship observed between the New Zea-
land score and the likelihood of agreement between clini-
cians. Despite a New Zealand score for all six cases which
merited revascularisation there were a significant number
of decisions to manage patients medically in more than
Table 3: Mean preferred category of treatment (score of 1 = definite surgery and 5 = definite medical therapy, see methods section) 
and agreement of voting between rounds for all specialists (weighted Kappa,) for each of the six case scenarios
Mean preferred treatment category Kappa (round 1 vs round 2)
Round 1 Round 2
Patient A 2.8 3.3 0.47
Patient B 1.3 1.2 0.22
Patient C 2.4 2.9 0.24
Patient D 1.2 1.3 0.15
Patient E 3.5 3.8 0.59
Patient F 2.7 1.7 0.51
Table 4: Comparison of treatment category between voting in round 1 and round 2 (N = number of votes for all 6 case scenarios)
Treatment choice Round 1 N Round 2 N Total N
Surgery 151 141 292
Medical/surgery 27 23 50
Angioplasty 66 70 136
Medical/angioplasty 49 68 117
Medical only 24 13 37
Total 317 315 632
χ2 test: 7.24, p = 0.124Journal of Cardiothoracic Surgery 2006, 1:2 http://www.cardiothoracicsurgery.org/content/1/1/2
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one third of cases (35%). This was consistent between car-
diologists (35%) and cardiac surgeons (36%).
Discussion
There is no widely accepted clinical pathway for assessing
CHD patients for revascularisation following coronary
angiography. In tertiary centres with cardiac surgery on-
site, the cardiologist may have the opportunity to discuss
the case and angiographic findings directly with a cardiac
surgeon. This can occur on an ad hoc or a formal basis
such as at an open clinical meeting. Rarely does this occur
in a dynamic, daily, case by case basis. For cardiologists
working in non-surgical centres discussion with a cardiac
surgeon is often more difficult and dynamic discussion
may not take place. In all situations the cardiologist com-
monly acts as the gatekeeper for angiography and revascu-
larisation. New developments in information technology
with high speed electronic digital links may facilitate for-
mal interactive discussion between specialists but such
systems are not yet widely available. Such discussions
should not take place with the patient lying waiting on the
cardiac catheter laboratory table.
This study highlights a number of issues. Firstly, some var-
iation in the use of coronary revascularisation therapy is
due to variations between individual clinician's working
practices. Secondly, this variation was greatest between
surgeons and interventional cardiologists. This supports
findings in other areas of clinical medicine where clinical
specialists who perform a procedure are more likely to
consider it to be appropriate in certain case scenarios [12].
Cardiologists have, at best, only moderate agreement
among themselves in the form of treatment chosen for
these six cases despite all six scoring highly using the New
Zealand system and using the criteria from the ACRE
study. Cardiologists clearly add variability to the decision
process even before discussion with a surgeon has taken
place. Surgeons had even less agreement among them-
selves at baseline. The combined effect of these variations
could account for a significant degree of variability in use
and choice of revascularisation therapy in routine clinical
practice.
Discussion between rounds appeared to improve agree-
ment among surgeons and cardiologists although the
choice of treatments did not change significantly. This
indicates that such discussion may, at least, reduce the var-
iability of decision-making but may not change the over-
all utilisation of revascularisation therapy. Similar
discussions might produce more consistent decisions in
clinical practice but may be practically difficult within cur-
rent systems of healthcare. Ideally the main carers for a
patient such as the community practitioner, the cardiolo-
gist and a cardiac surgeon would represent the profes-
sional core of the discussion group with the patient and,
ideally, a close family member also being involved. This
might be particularly useful in clinical scenarios where
indications for revascularisation were strong but where
there was significant co-morbidity which influenced the
decision-making process. While this could be done for
elective cases it would be very difficult to do in emergency
situations.
Similar multidisciplinary approaches to clinical decisions
are now widely used in oncology [13-15] and have been
proposed previously for cardiac revascularisation [16,17].
As interventional cardiologists increasingly treat patients
with multi-vessel disease [18] the need to carefully assess
the range of options available to the patient is extremely
important.
Conclusion
In this typical case series, there was poor agreement
between cardiac clinical specialists in the choice of treat-
ment offered to patients. Open discussion appeared to
improve agreement. These findings strongly support the
need for decisions to revascularise patients to be made by
a multidisciplinary panel using agreed criteria.
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